161 related articles for article (PubMed ID: 2407166)
21. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of detection of colorectal neoplasia using an immunochemical occult blood test in symptomatic referred patients: comparison of retrospective and prospective studies.
Miyoshi H; Oka M; Sugi K; Saitoh O; Katsu K; Uchida K
Intern Med; 2000 Sep; 39(9):701-6. PubMed ID: 10969900
[TBL] [Abstract][Full Text] [Related]
23. Value of retesting subjects with a positive Hemoccult in screening for colorectal cancer.
Kewenter J; Engarås B; Haglind E; Jensen J
Br J Surg; 1990 Dec; 77(12):1349-51. PubMed ID: 2276015
[TBL] [Abstract][Full Text] [Related]
24. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
[TBL] [Abstract][Full Text] [Related]
25. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
26. Fecal occult blood testing: comparative evaluation of a two-hole versus a three-hole single slide test.
Porschen R; Kruis W; Strohmeyer G
Hepatogastroenterology; 1993 Apr; 40(2):191-3. PubMed ID: 8509054
[TBL] [Abstract][Full Text] [Related]
27. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
28. [Use of the Hemoccult Test in the detection of colorectal cancer].
Janković S; Kostić Z; Marinković J; Radovanović Z
Vojnosanit Pregl; 1994; 51(3):220-3. PubMed ID: 8560835
[TBL] [Abstract][Full Text] [Related]
29. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects.
Kewenter J; Brevinge H; Engarås B; Haglind E; Ahrén C
Scand J Gastroenterol; 1994 May; 29(5):468-73. PubMed ID: 8036464
[TBL] [Abstract][Full Text] [Related]
30. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
Rasmussen M; Fenger C; Kronborg O
Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
[TBL] [Abstract][Full Text] [Related]
32. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
[TBL] [Abstract][Full Text] [Related]
33. [Colorectal cancer: assessment of two-yearly screening of the population in health care examination centres].
Steinmetz J; Spyckerelle Y; Giordanella JP
Presse Med; 2003 Oct; 32(32):1496-9. PubMed ID: 14534466
[TBL] [Abstract][Full Text] [Related]
34. Analysis of screening data: colorectal cancer.
Gyrd-Hansen D; Søgaard J; Kronborg O
Int J Epidemiol; 1997 Dec; 26(6):1172-81. PubMed ID: 9447396
[TBL] [Abstract][Full Text] [Related]
35. [Value of the study of occult fecal blood with Hemoccult II in 211 symptomatic patients controlled by total colonoscopy].
Morini S; Manurita L; Stroppa I; Bassi O
Minerva Med; 1984 Apr; 75(17):963-6. PubMed ID: 6728249
[TBL] [Abstract][Full Text] [Related]
36. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
37. Interval cancers in screening with fecal occult blood test for colorectal cancer.
Jensen BM; Kronborg O; Fenger C
Scand J Gastroenterol; 1992 Sep; 27(9):779-82. PubMed ID: 1411286
[TBL] [Abstract][Full Text] [Related]
38. The estimation of sensitivity and specificity in colorectal cancer screening methods.
Walter SD; Frommer DJ; Cook RJ
Cancer Detect Prev; 1991; 15(6):465-9. PubMed ID: 1782636
[TBL] [Abstract][Full Text] [Related]
39. Patterns of occult bleeding in asymptomatic colorectal cancer.
Ahlquist DA; McGill DB; Fleming JL; Schwartz S; Wieand HS; Rubin J; Moertel CG
Cancer; 1989 May; 63(9):1826-30. PubMed ID: 2702590
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
